Health Bureau Unveils Updated Chronic Disease Care Fees for 2025
Navigating healthcare costs can be challenging, especially for individuals managing chronic conditions. The Health Bureau has announced important updates to the Chronic Disease Co-care Pilot Scheme (CDCC Pilot Scheme) that aim to make medical care more accessible and affordable for patients.
Starting September 1, 2025, patients will see some changes in consultation fees for screening and treatment. For those undergoing disease screenings, family doctors can now set co-payment fees with a maximum cap of $120. This approach provides patients with a clear understanding of potential out-of-pocket expenses, removing some of the financial uncertainty surrounding medical care.
The fee landscape for treatment-related consultations shows remarkable stability. Out of 971 service points, 874 will maintain their current co-payment rates. While 89 service points will increase their fees (ranging from $20 to $300), eight will actually reduce their costs, offering some relief to patients. Importantly, 617 service points will align with the government-recommended consultation fee of $150 or below, with the median co-payment remaining steady at $150.
The overall fee increase is modest, averaging just 3.1%, demonstrating a careful balance between supporting healthcare providers and maintaining affordability for patients. This approach reflects a nuanced understanding of the financial challenges faced by individuals managing chronic health conditions.
The scheme’s expansion is particularly noteworthy. The Health Bureau plans to gradually include patients from Hospital Authority General Out-patient Clinics (GOPCs) and the General Outpatient Clinic Public-Private Partnership (GOPC PPP) Programme. Eligible patients can expect invitation letters by post, with GOPC patients receiving invitations next month and GOPC PPP Programme participants hearing from the bureau early next year.
At its core, the CDCC Pilot Scheme operates on a co-care model, sharing costs between patients and the government. This approach significantly reduces the financial burden on individuals requiring ongoing medical attention. Family doctors play a crucial role, offering personalized care and tailoring screening and treatment plans to individual patient needs.
The benefits extend beyond mere financial considerations. The scheme provides a structured pathway for managing chronic conditions, emphasizing early detection and consistent treatment. By maintaining relatively stable co-payments and involving family doctors who understand patients’ medical histories, the program aims to improve overall health outcomes.
Patients can take comfort in knowing that the majority of service points are committed to keeping care affordable. The median co-payment of $150 ensures that most individuals will not face significant cost increases. Moreover, the cap on screening fees at $120 provides additional financial predictability for those managing chronic health conditions.
As healthcare continues to evolve, initiatives like the CDCC Pilot Scheme demonstrate a forward-thinking approach to chronic disease management. By balancing cost, accessibility, and personalized care, the Health Bureau is working to create a more supportive healthcare environment for patients with ongoing medical needs.
For those receiving invitations, this represents an opportunity to engage with a comprehensive care model designed to support long-term health management. The phased rollout ensures a smooth transition, minimizing disruption to existing healthcare services while expanding access to critical medical support.
